Characterization of macrophage proteases involved in the ingestion of antigen—antibody complexes by the use of protease inhibitors  by Nagai, Kenji et al.
Volume 92, number 2 FEBS LETTERS August 1978 
CHARACTERIZATION OF MACROPHAGE PROTEASES INVOLVED IN THE INGESTION 
OF ANTIGEN-ANTIBODY COMPLEXES BY THE USE OF PROTEASE INHIBITORS 
Kenji NAGAI, Tohoru NAKAMURA and Jiro KOYAMA 
Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, 060, Japan 
Received 12 June 1978 
1. Introduction 
The ingestion of antigen-antibody complexes 
preceding the intracellular digestion by phagocytes 
can be inhibited by potent inhibitors of serine sterases 
such as diisopropylphosphofluoridate (DFP), p-nitro- 
phenyl phosphonates, cyclohexyl alkylphosphono- 
fluoridates, and cyclohexyl phenylalkylphosphono- 
fluoridates [1,2] . The available vidence suggests 
that active and/or stimulus-activated serine esterases 
are required for the process of ingestion. 
In order to characterize the serine sterases involved, 
it was attempted to study effects of various protease 
inhibitors with known specificities on the ingestive 
activity of guinea pig peritoneal macrophages against 
sensitized sheep erythrocytes [EA] . Among the 
inhibitors tested, DFP, 1-L-tosylamido-2-phenylethyl- 
chloromethylketone (TPCK), and chymostatin alone 
were found to reduce the ingestive activity of macro- 
phages. These results are reported in this paper, 
indicating that the esterases required for the ingestion 
are presumably chymotrypsin-like proteases. 
2. Materials and methods 
2,1. Chemicals 
DFP, TPCK, and I-chloro-3-tosylamido-7-amino- 
L-2-heptanone (TLCK) were products of Sigma 
Abbrevkztionr DFP, diisopropylphosphofluoridates; EA, 
sensitized sheep erythrocytes; TPCK, 1-L-tosylamido-2- 
phenylethylchloromethylketone; TLCK, 1-chloro-3-tosyl- 
amido-7-amino-L-2-heptanone; MEM-HEPES, the minimal 
essential medium supplemented with 20 mM 4-(2hydroxy- 
ethyl)-l-piperazine ethanesulfonic acid; DMSO, dimethyl- 
sulfoxide 
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Chemical Company (USA). Various protease 
inhibitors from actinomycete f rmentation, i.e., 
chymostatin, antipain, pepstatin, elastatinal, and 
leupeptins were kindly supplied by the Institute for 
Microbial Chemistry, Tokyo. 
2.2. Macrophages 
The methods for harvesting and cultivating uinea 
pig peritoneal macrophages were essentially the same 
as those described by Shinomiya nd Koyama [3]. 
Peritoneal macrophages were obtained from guinea 
pigs injected intraperitoneally with 20 ml of sterilized 
liquid paraffin 4 days before harvest. Peritoneal cells 
were washed 3 times with the minimal essential 
medium supplemented with 20 mM 4-(2-hydroxy- 
ethyl)-I-piperazine ethanesulfonic a id (MEM-HEPES) 
[4] , and 2.5 X 10” peritoneal cells in 2.5 ml of MEM 
containing 5% fetal calf serum were plated in plastic 
dishes (Falcon, 35 X 10 cm), each containing acover 
glass. After incubation at 37°C for 20 h in a CO,& 
incubator, the cover glasses containing the adherent 
macrophages were washed 3 times with MEM-HEPES 
to remove the non-adherent cells. 
2.3. Sensitized sheep erythrocytes 
One ml of a 10% suspension of sheep erythrocytes 
in MEM-HEPES was incubated with 1 ml of rabbit 
IgG containing 4 AU of antibody to erythrocyte at 
37’C for 15 mm, and used for experiments after 
lo-fold dilution with MEM-HEPES. The IgG used 
was purified from rabbit antiserum by fractionation 
with ammonium sulfate and DEAE-cellulose chro- 
matography [5]. One AU was defined as a minimum 
amount of antibody capable of agglutinating 0.025 ml 
of a 2% suspension of erythrocytes. 
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2.4. Ingestion of sensitized erythrocytes by 
macrophages 
The method for measuring the ingestive activity of 
macrophages was essentially the same as that of 
Griffin et al. [6] . The cover glass cultures of macro- 
phageg were covered with 2 ml of MEM-HEPES in 
dishes and kept at 37’C for 15 min. 0.2 ml of 
EA was added to each dish, and the reaction mixtures 
were incubated at 37°C for 60 min in a CO*--air 
incubator. 
After incubation, the macrophage monolayers 
were washed 3 times with MEM-HEPES and 
further incubated with 2 ml of IO-fold diluted MEM- 
HEPES to lyse EA not ingested. The macrophage 
monolayers thus treated were fured with 2.5% 
glutaraldehyde in 0.1 ml of sodium cacodylate 
buffer, pH 7.2, at 4°C for 10 min [7] , and number of 
EA ingested per each cell of macrophage was counted 
by a microscope. The ingestive activity of macro- 
phages was expressed by an average number of 
ingested EA with the standard error, which was cal- 
culated using 30 cells of macrophage. 
Under the condition used, number of EA ingested 
by each cell of macrophage increased rapidly up to 
60 min (fig.1). 
3. Results 
The effects of various protease inhibitors on 
phagocytosis were determined by adding each 
inhibitor to a macrophage monolayer 15 min before 
the initiation of phagocytosis and comparing numbers 
of ingested EA in the presence or absence of the 
inhibitor. Among the inhibitors tested, DFP, TPCK, 
and chymostatin alone, each being a potent inhibitor 
of chymotrypsin [8-lo], cnuld inhibit the ingestive 
activity of macrophages (fig.2). These effects increased 
as the concentration of each inhibitor wasincreased 
(fig.3). On the other hand, TLCK, antipain, pepstatin, 
elastatinal, and leupeptins could not significantly 
alter the ingestive activity though these inhibitors at 
the same concentrations inhibited strongly trypsin, 
papain, pepsin, elastase, and trypsin, respectively 
[ 1 l-1 51. The inhibition with DFP, TPCK or 
chymostatin may directly result from that of 
certain chymotrypsin-like enzyme involved in the 
process of ingestion since these inhibitors failed to 
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Fig.1. Ingestion of EA by macrophages. The time course of 
ingestion of EA was determined, as described in section 2 
(o-o-o). The ingestion of erythrocytes also was measured 
as a control (e-o-0). 
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Fig.2. Inhibition of the ingestion with various protease 
inhibitors. Macrophages on cover glasses covered with 1.8 ml 
of MEM-HEPES in dishes were incubated with 0.2 ml of DFP 
in isopropanol, chymostatin (CH) in dimethylsulfoxide 
(DMSO), antipain (AN) in H,O, pepstatin (PE) in H,O, 
elastatinal (EL) in H, 0, leupeptins (LE) in H, 0, TPCK in 
DMSO, and TLCK in H,O, respectively. After incubation at 
37°C for 15 min, the ingestive activities of macrophages were 
measured, as described in section 2. The final concentration 
of each inhibitor was 100 ng/ml, excepting 10 mM of DFP. 
As controls, macrophages were similarly treated with 0.2 ml 
of isopropanol, H,O, and DMSO, respectively. 
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Fig.3. Inhibition of the ingestion with DFP, chymostatin, and TPCK. Inhibition was measured by two types of procedure: 
(1) macrophages on cover glasses covered with 1.8 ml of MEM-HEPES in dishes were incubated with 0.2 ml of DFP in isopropanol 
(A), chymostatin in DMSO (B), and TPCK in H,O (C), respectively. After incubation at 37’C for 15 (e-o-o) or 60 min(o-o-o), 
the macrophages were washed five times with MEM-HEPES, and tested for ingestion of EA, as described in section 2; 
and (2) Inhibition with each inhibitor was measured by the same procedure as described in fig.1 (v-v-v). In all cases, macro- 
phages were similarly treated with 0.2 ml of isopropanol, H,O, and DMSO, respectively, as controls. The final concentration of 
each inhibitor was shown on the absissa. 
alter macrophage viability, as assessed by trypan 
blue uptake [16] . 
In order to discern whether pretreatment with 
TPCK or chymostatin affects the ingestive activity of 
macrophages, the effects were determined by 
measuring the ingestion by cells pretreated with 
these inhibitors and washed before the initiation 
of phagocytosis. As in the case of DFP [2], the 
pretreatment with TPCK reduced the ingestion 
though the inhibition was always less than that due to 
the presence of TPCK at the same concentration 
during phagocytosis (fig.2). To the contrary, the 
effect of pretreatment with chymostatin was essen- 
tially nonexistent. This may be because chymostatin 
inhibits reversibly chymotrypsin-like proteases though 
both DFP and TPCK do irreversibly by phosphorylat- 
ing or alkylating the enzymes, respectively. 
presented some evidence that the serine esterase 
4. Discussion 
With the development of the lysosomal concept, 
the processes governing the intracellular digestion of 
ingested antigen-antibody complexes have been 
clarified [ 17,181. In contrast, the mechanisms which 
regulate the ingestive process of phagocytosis have 
remained to be solved. Through the use of many 
potent serine esterase inhibitors, Pearlman et al. [l] 
and Musson and Becker [2] have presented evidence 
that serine esterases were required for the ingestive 
process of phagocytosis by rabbit and human 
neutrophils. 
The results presented in this paper extended to 
guinea pig peritoneal macrophages the previous 
finding by Musson and Becker [2] that a DFP- 
sensitive serine esterase was involved in the ingestive 
activity of phagocytes. In addition, this paper 
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involved was a chymotrypsin-like protease, since 
DFP as well as two well-known inhibitors of 
chymotrypsin, TPCK and chymostatin, inhibited 
strongly the ingestive activity of macrophages. This 
characterization was further supported by the failure 
of TLCK, antipain, pepstatin, elastatinal, and leu- 
peptins to inhibit the ingestive process of phagocytosis. 
Both DFP and TPCK were found to reduce the 
ingestive activity even when inhibition was determined 
by measuring the ingestion by macrophages pretreated 
with these inhibitors, though the inhibition by 
pretreatment was less than that due to the presence 
of inhibitors during phagocytosis. As Musson and 
Becker [2] proposed, this difference in the inhibition 
profiles by two types of inhibition procedure seems 
to be accounted for by the mechanism that the 
ingestive process may require two types of serine 
esterase: an active esterase and another esterase which 
is normally in a proesterase form and activated by 
the interaction of phago<ytes with antigen-antibody 
complexes through Fc receptors on the cell surface. 
If such two types of esterase participated in the 
ingestive process, both of them should be chymo- 
trypsinlike enzymes. However, the results obtained 
so far are not sufficient o conclude that more than 
one type of esterase are involved in the ingestive 
process, since the evidence, by its nature, is indirect. 
Recently, a neutral protease susceptible to inhib- 
itory activities of DFP and chymostatin was partially 
purified by Suzuki and Murachi [ 191 from the lysate 
of rat peritoneal macrophages. Whether this chymo- 
trypsin-like protease functions directly in the ingestive 
process has also been uncertain. Further biochemical 
characterization f the active and stimulus-activated 
esterases is required for the elucidation of molecular 
events involved in phagocytic processes. 
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